Literature DB >> 19623668

Epidemiologic risk profile of infection with different groups of human papillomaviruses.

Paul K S Chan1, Wendy C S Ho, Martin C S Wong, Alexander R Chang, Josette S Y Chor, Mei-Yung Yu.   

Abstract

This study identified the age-specific prevalence and epidemiologic risk profile for infection with different groups and species of human papillomaviruses (HPV). Structured interview and HPV testing were conducted for 2,604 Chinese women self-referred for cervical screening. Independent risk factors for infection were identified by multiple logistic regressions. Overall, a major peak of HPV infection was observed at women aged 26-30 years, and a minor peak at 46-55 years. This pattern was observed for high-risk, low-risk, and alpha-5/7/9 HPVs; but alpha-3/6 HPVs showed peaks of similar magnitudes in young and older women. Independent risk factors for HPV infection (all types combined) included younger age (OR [95% CI] for >55 vs. < or =30 years = 0.22 [0.09-0.55]; 31-45 vs. < or = 30 years = 0.57 [0.33-0.99]), having > or =4 lifetime sexual partners (2.28 [1.06-4.88]), and smoking (2.24 [1.22-4.10]). Young age and smoking were the most consistent independent risk factors observed across different HPV groups. The risk profile for high-risk HPV was similar to alpha-5/7/9. Single-type infection was associated with having more sexual partners, higher education level and oral contraception; whereas multiple-type infection was associated with smoking. In conclusion, a U-shaped age-specific prevalence curve was observed for HPV infection overall, but with a different pattern for different HPV species. Different HPV groups showed variations in their risk profiles. These data are useful for formulating preventative strategy for HPV-related diseases. Catch-up vaccination program in Hong Kong should cover a wider age group as the first peak of infection occurred relatively late.

Entities:  

Mesh:

Year:  2009        PMID: 19623668     DOI: 10.1002/jmv.21575

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Revisiting knowledge, attitudes and practice (KAP) on human papillomavirus (HPV) vaccination among female university students in Hong Kong.

Authors:  Jonathan Tin Chi Leung; Chi-Kin Law
Journal:  Hum Vaccin Immunother       Date:  2018-01-18       Impact factor: 3.452

2.  Human papillomavirus DNA detection in menstrual blood from patients with cervical intraepithelial neoplasia and condyloma acuminatum.

Authors:  Sze Chuen Cesar Wong; Thomas Chi Chuen Au; Sammy Chung Sum Chan; Charles Ming Lok Chan; Money Yan Yee Lam; Benny Chung Ying Zee; Wei Mei Pong; Anthony Tak Cheung Chan
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

Review 3.  The impact of smoking on HPV infection and the development of anogenital warts.

Authors:  Reto Kaderli; Beat Schnüriger; Lukas E Brügger
Journal:  Int J Colorectal Dis       Date:  2014-06-17       Impact factor: 2.571

4.  Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study.

Authors:  Jing Ye; Xiaodong Cheng; Xiaojing Chen; Feng Ye; Weiguo Lü; Xing Xie
Journal:  Virol J       Date:  2010-03-23       Impact factor: 4.099

5.  Population-based study on the prevalence of and risk factors for human papillomavirus infection in Qujing of Yunnan province, Southwest China.

Authors:  Lu-lu Sun; Qiong Jin; Hui Li; Xian-rong Zhou; Zhi-qin Song; Xue-mei Cheng; Tao Tao; Bing Liang; Lin Xu; Yu-rong Wang; Yan Zhen; Ji-wen He; Keng Shen
Journal:  Virol J       Date:  2012-08-08       Impact factor: 4.099

6.  Prevalence and risk factors of Human Papillomavirus (HPV) infection in southern Chinese women - a population-based study.

Authors:  Stephanie Si Liu; Kelvin Yuen Kwong Chan; Rebecca Ching Yu Leung; Karen Kar Loen Chan; Kar Fai Tam; May Hiu Mei Luk; Sue Seen Tsing Lo; Daniel Yee Tak Fong; Annie Nga Yin Cheung; Zhong Qiu Lin; Hextan Yuen Sheung Ngan
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

Review 7.  Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer.

Authors:  Rabia Faridi; Amreen Zahra; Khalida Khan; Muhammad Idrees
Journal:  Virol J       Date:  2011-06-03       Impact factor: 4.099

8.  Knowledge, attitude, practice and barriers on vaccination against human papillomavirus infection: a cross-sectional study among primary care physicians in Hong Kong.

Authors:  Martin C S Wong; Albert Lee; Karry L K Ngai; Josette C Y Chor; Paul K S Chan
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

9.  Prevalence and correlation of human papillomavirus genotypes with clinical factors in cervical samples from Mexican women.

Authors:  Fabiola Hernández-Rosas; Erika Orozco-Hernández; Liliana Maza-Sánchez; Pamela Citlalli Salgado-García; Enrique Navarro-Vidal; Mercedes Piedad de León-Bautista
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-22

10.  Prevalence, Genotype Distribution and Risk Factors for Cervical Human Papillomavirus Infection in the Grand Tunis Region, Tunisia.

Authors:  Monia Ardhaoui; Emna Ennaifer; Hajer Letaief; Rejaibi Salsabil; Thalja Lassili; Karim Chahed; Souha Bougatef; Asma Bahrini; Emna El Fehri; Kaouther Ouerhani; Adela Paez Jimenez; Ikram Guizani; Med Samir Boubaker; Nissaf Bouafif Ép Ben Alaya
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.